<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ojog
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Obstetrics and Gynecology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2160-8792
   </issn>
   <issn publication-format="print">
    2160-8806
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ojog.2024.149121
   </article-id>
   <article-id pub-id-type="publisher-id">
    ojog-136212
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Cystic Degeneration of Uterine Myoma Simulating Ovarian Cancer in Postpartum: A Case Report at the Teaching Hospital of Angre
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Roland
      </surname>
      <given-names>
       Adjoby
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Ndrin Denis
      </surname>
      <given-names>
       Effoh
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Soh Victor
      </surname>
      <given-names>
       Koffi
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Okoin Paul José
      </surname>
      <given-names>
       Loba
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Ngolo Alassane
      </surname>
      <given-names>
       Soro
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Yapo Privat
      </surname>
      <given-names>
       Akobé
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Ramata
      </surname>
      <given-names>
       Kouakou-Kouraogo
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Michelle
      </surname>
      <given-names>
       Gadji
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aObstetric Gynecology Department of Angre’s Teaching Hospital, Abidjan, Côte d’Ivoire
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     29
    </day> 
    <month>
     08
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    14
   </volume> 
   <issue>
    09
   </issue>
   <fpage>
    1522
   </fpage>
   <lpage>
    1528
   </lpage>
   <history>
    <date date-type="received">
     <day>
      23,
     </day>
     <month>
      June
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      22,
     </day>
     <month>
      June
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      22,
     </day>
     <month>
      July
     </month>
     <year>
      2024
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    The transformation of uterine fibroids is common in relation to their development. Giant forms of cystic degeneration are rare. They raise diagnostic difficulties with other pelvic tumors, such as ovarian tumors and leiomyosarcomas. Magnetic resonance imaging specifies the original organ, the volume and the main relationships of fibromyoma with adjacent structures. The diagnosis of certainty is based on laparotomy coupled with histology. The authors illustrate these difficulties by observing a giant cystic degenerative fibroma in a 26-year-old G1P1 woman in the postpartum period.
   </abstract>
   <kwd-group> 
    <kwd>
     Fibromyoma
    </kwd> 
    <kwd>
      Uterine Neoplasia
    </kwd> 
    <kwd>
      Pelvic Tumor
    </kwd> 
    <kwd>
      MRI
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Uterine fibroids are the most common pelvic tumours, occurring in nearly 80% - 100% of black women over the age of 35 <xref ref-type="bibr" rid="scirp.136212-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.136212-2">
     [2]
    </xref>. These fibroids of monoclonal origin, of variable size and location, are unpredictable in their evolution. They may undergo structural changes related to several factors including hormonal factors <xref ref-type="bibr" rid="scirp.136212-3">
     [3]
    </xref>-<xref ref-type="bibr" rid="scirp.136212-5">
     [5]
    </xref>. The myomatous uterus may have one or more nuclei that may undergo hyaline, myxoid, or cystic degeneration. Hyaline degeneration, the most common, is observed in 60% of cases. The cystic degeneration nucleus, observed in 4% of cases, can simulate ovarian cancer <xref ref-type="bibr" rid="scirp.136212-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.136212-6">
     [6]
    </xref>. Cystic degeneration of uterine leiomyoma is an atypical presentation with risk factors including a family history of uterine leiomyoma, nulliparity, early menarche, and late onset of menopause with good prognosis. <xref ref-type="bibr" rid="scirp.136212-7">
     [7]
    </xref> <xref ref-type="bibr" rid="scirp.136212-8">
     [8]
    </xref>. We report the case of a young woman who presented in the postpartum period with exponential growth of a fibroid linked to a cystic transformation simulating ovarian cancer. The rarity of this evolution and the context of postpartum are the interests of this observation.</p>
  </sec><sec id="s2">
   <title>2. Case Report</title>
   <p>OAD, a 26-year-old housewife with no particular history, G1P1 was referred to the Teaching Hospital of Angré for suspected postpartum ovarian cancer. The patient gave birth 3 months ago to a stillborn weighing 2200 g associated with an undiagnosed pelvic mass during poor quality prenatal consultations. The obstetric course was simple, but faced with the sudden increase in the volume of the abdomen with repercussions on the general condition, persistent anemia and malnutrition, she consulted in a health structure. The clinical examination revealed an altered general condition, a distended and painful abdomen on palpation, and no signs of fluid effusion. The uterus was not palpable but the cervix appeared normal during the vaginal speculum examination. After an abdominopelvic ultrasound, the uterus and ovaries could not be visualized separately from the lesion, with the possibility that it was an etiology of ovarian tumor, mesothelial cyst, cystic teratoma, endometriotic cyst, and cystic lymphangioma, omental cyst, and mesenteric cysts. Ovarian cancer was suspected on the basis of an abdominopelvic MRI which had objectified a right ovarian tumor with abundant ascites (<xref ref-type="fig" rid="fig1">
     Figure 1
    </xref>). The tumor marker search was positive for CA 125 (59 IU/ml), AFP (8.44 IU/ml) normal ACE. A multidisciplinary consultation meeting suggested diagnostic laparoscopy. Laparoscopy for a biopsy sample could not be performed due to the financial cost. In such circumstances, it is exploratory laparotomy which allows the diagnosis to be made. An exploratory laparotomy was decided at the Teaching Hospital of Angré after preoperative preparation based on blood transfusions. The blood test showed hemoglobin = 8.5g% and TP = 60%. During the operation, a large abdominal tumor was found to adhere to all the abdominal organs with which it is in contact (<xref ref-type="fig" rid="fig2">
     Figure 2
    </xref>). The careful adhesiolysis highlights a fibromatous mass letting out about 6 liters of a citrine-looking liquid that we aspire. The mass was connected to the uterus by a broad implantation base making us evoke a giant fibroma in hydropic degeneration classified FIGO VII (<xref ref-type="fig" rid="fig3">
     Figure 3
    </xref>). We then perform a myomectomy allowing us to preserve the fertility of this young patient without a living child. The postoperative course was simple and after postoperative transfusions, the patient was discharged on D7. Histology will subsequently confirm the clinical impression. The specimen’s histopathological study suggests a fibroid uterus with cystic degeneration. Microscopic examination revealed mesenchymal tumor tissue with rounded edges, composed of cellular smooth muscle cell proliferation, partly loose, and irregularly aligned. The tumor cells are round with oval nucleated, partly cigar-shaped, relatively fine chromatin, and eosinophilic cytoplasm. Locally, there are islands of preservation, and a cystically dilated endometrial stroma. A hemosiderophage is seen. Histologic signs of malignancy were not found.</p>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>Figure 1. MRI appearance of a large ovarian tumour 27 cm × 21 cm × 21 cm.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="" />
   </fig>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>Figure 1. MRI appearance of a large ovarian tumour 27 cm × 21 cm × 21 cm.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1433481-rId13.jpeg?20240925092704" />
   </fig>
   <fig id="fig1" position="float">
    <label>Figure 1</label>
    <caption>
     <title>Figure 1. MRI appearance of a large ovarian tumour 27 cm × 21 cm × 21 cm.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1433481-rId14.jpeg?20240925092704" />
   </fig>
   <fig id="fig2" position="float">
    <label>Figure 2</label>
    <caption>
     <title>Figure 2. Operative view of a large cystic-tissue tumour attached to the uterine fundus in favor of a degenerating uterine myoma classified FIGO VII without associated ascites.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="" />
   </fig>
   <fig id="fig2" position="float">
    <label>Figure 2</label>
    <caption>
     <title>Figure 2. Operative view of a large cystic-tissue tumour attached to the uterine fundus in favor of a degenerating uterine myoma classified FIGO VII without associated ascites.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1433481-rId15.jpeg?20240925092704" />
   </fig>
   <fig id="fig2" position="float">
    <label>Figure 2</label>
    <caption>
     <title>Figure 2. Operative view of a large cystic-tissue tumour attached to the uterine fundus in favor of a degenerating uterine myoma classified FIGO VII without associated ascites.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1433481-rId16.jpeg?20240925092704" />
   </fig>
   <fig id="fig3" position="float">
    <label>Figure 3</label>
    <caption>
     <title>Figure 3. Individualisation of uterine appendices and enucleation of uterine fibroid followed by padding.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="" />
   </fig>
   <fig id="fig3" position="float">
    <label>Figure 3</label>
    <caption>
     <title>Figure 3. Individualisation of uterine appendices and enucleation of uterine fibroid followed by padding.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1433481-rId17.jpeg?20240925092704" />
   </fig>
   <fig id="fig3" position="float">
    <label>Figure 3</label>
    <caption>
     <title>Figure 3. Individualisation of uterine appendices and enucleation of uterine fibroid followed by padding.</title>
    </caption>
    <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/1433481-rId18.jpeg?20240925092704" />
   </fig>
  </sec><sec id="s3">
   <title>3. Discussion</title>
   <p>Fibroids are increasing in the female population with an incidence of 40% - 60% at the age of 35 <xref ref-type="bibr" rid="scirp.136212-2">
     [2]
    </xref>. However, fibroids are increasingly observed in adolescent girls <xref ref-type="bibr" rid="scirp.136212-9">
     [9]
    </xref> <xref ref-type="bibr" rid="scirp.136212-10">
     [10]
    </xref>. Fibroids are more common in cases of high body mass index <xref ref-type="bibr" rid="scirp.136212-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.136212-11">
     [11]
    </xref>. In our observation, however, it was a young black woman with a low BMI (Height = 158 cm, Weight = 56 Kg), aged 26 years in postpartum period. They are observed in about 3% - 12% of pregnant women <xref ref-type="bibr" rid="scirp.136212-9">
     [9]
    </xref> <xref ref-type="bibr" rid="scirp.136212-11">
     [11]
    </xref>. In the literature, potential protective factors against fibroids include having children, a hygienic diet, oral contraception and smoking (anti-estrogen effect) <xref ref-type="bibr" rid="scirp.136212-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.136212-13">
     [13]
    </xref>. Most fibroids are multiple, and each grows from a single monoclonal smooth muscle cell. Because they respond to estrogen, fibroids tend to increase in size during the fertile period and decrease after menopause <xref ref-type="bibr" rid="scirp.136212-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.136212-14">
     [14]
    </xref>. These fibroids can grow to the point that their blood supply becomes insufficient and degenerate. Degeneration is described as hyaline, myxoid, calcified, cystic in 4% of cases, greasy, red (usually only during pregnancy), or necrotic <xref ref-type="bibr" rid="scirp.136212-4">
     [4]
    </xref> <xref ref-type="bibr" rid="scirp.136212-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.136212-13">
     [13]
    </xref>. Although the patient is often concerned about the possibility of cancer, sarcomatous transformation is rare or even discussed <xref ref-type="bibr" rid="scirp.136212-5">
     [5]
    </xref> <xref ref-type="bibr" rid="scirp.136212-10">
     [10]
    </xref> <xref ref-type="bibr" rid="scirp.136212-15">
     [15]
    </xref>.</p>
   <p>If the fibroids grow and degenerate intense, acute or chronic pain or simple heaviness may result. Urinary symptoms such as pollakiuria or imperiosity may result from the compression of the bladder and compression of the ureters which may cause ureterohydronephrosis <xref ref-type="bibr" rid="scirp.136212-16">
     [16]
    </xref>. In our observation, the alteration of the general condition, the signs of pelvic compression and the rapid growth in a few weeks of a pelvic tumor towards the xiphoid region associated with the positivity of markers pointed to a malignant process. An increase in fibroids in the postpartum can be observed because prolactin has mitotic activity in the myoma cells and on normal myometrial cells <xref ref-type="bibr" rid="scirp.136212-15">
     [15]
    </xref>.</p>
   <p>Ultrasound is the examination of choice for diagnosis, but in case of a large fibroid, atypical or in case of polymyomatous uterus or in case of associated uterine pathology such as adenomyosis, it is not specific or in case of non-feasibility endovaginally as in patients always virgin <xref ref-type="bibr" rid="scirp.136212-13">
     [13]
    </xref>. The echogenicity of myomas depends on the relative proportion of smooth and connective muscle tissue, the extent of degeneration, and whether or not calcification is present <xref ref-type="bibr" rid="scirp.136212-3">
     [3]
    </xref> <xref ref-type="bibr" rid="scirp.136212-4">
     [4]
    </xref>. According to Yeh, ovarian origin can only be excluded if the ovaries are visualized and separated from the mass or the pedicle connecting the mass to the uterus. Ultrasound and Doppler visualization are not always easy <xref ref-type="bibr" rid="scirp.136212-17">
     [17]
    </xref>.</p>
   <p>Magnetic resonance imaging (MRI) is more interesting and allows for precise pre-therapeutic mapping, which is the gold standard of uterine pathology. In this case, MRI allows radiological staging of possible uterus cancer. According to Sotomayor, Magnetic resonance (MR) imaging is the most accurate imaging technique for the characterization of leiomyomas <xref ref-type="bibr" rid="scirp.136212-6">
     [6]
    </xref> <xref ref-type="bibr" rid="scirp.136212-18">
     [18]
    </xref>.</p>
   <p>In our case, the MRI was taken at fault and the exploratory laparotomy was able to correct the diagnosis. Indeed, according to Vladimiroff, atypical aspects due to degeneration lead to diagnostic confusion with adenomyosis, uterine sarcoma and ovarian cancer <xref ref-type="bibr" rid="scirp.136212-19">
     [19]
    </xref>.</p>
   <p>Myomas are generally responsible for fertility disorders, menopause and pelvic algias, and are one of the leading causes of premenopausal hysterectomy. Only symptomatic fibroids justify a therapeutic approach <xref ref-type="bibr" rid="scirp.136212-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.136212-9">
     [9]
    </xref> <xref ref-type="bibr" rid="scirp.136212-16">
     [16]
    </xref>. The young age of the patient justified the use of conservative treatment of the uterus irrefutably, through myomectomy if possible under cervico-isthmic withers. This technique minimizes blood loss and enucleation of multiple nuclei, reducing the rate of hysterectomy <xref ref-type="bibr" rid="scirp.136212-20">
     [20]
    </xref>. Histological examination remains essential for the confirmation of the diagnosis even if it is obvious. The mechanism of cystic degeneration has a multifactorial origin <xref ref-type="bibr" rid="scirp.136212-15">
     [15]
    </xref>. In the discovery of a large partially solid cystic mass and an elevated CA-125 level, the first differential diagnosis would be an ovarian malignancy. The exact etiology of ovarian malignancy is unknown. The strongest risk factor is a family or personal history of breast and/or ovarian cancer, all linked to the mutation of BRCA1 or BRCA2 genes <xref ref-type="bibr" rid="scirp.136212-21">
     [21]
    </xref> <xref ref-type="bibr" rid="scirp.136212-22">
     [22]
    </xref>.</p>
  </sec><sec id="s4">
   <title>4. Conclusion</title>
   <p>Uterine fibroids are the most common pelvic tumor in gynaecology. They are usually asymptomatic but of unpredictable evolution including cystic degeneration even after treatment. Myoma management requires a definite diagnosis after accurate mapping by pelvic ultrasound or second-line MRI and exploratory laparotomy as a last resort.</p>
  </sec><sec id="s5">
   <title>Acknowledgments</title>
   <p>None.</p>
  </sec><sec id="s6">
   <title>Consent</title>
   <p>Informed consent was obtained from the patient and this research received no external funding.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.136212-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Koffi, A.B.D., Olou, N.L., Fomba, M., Séni, K., Horo, A., Touré-Ecra, A.F. (2013) Uterine Fibroid Surgery: Assessment of Five Years of Activity at the Gynecology Department of CHU de Yopougon (Abidjan). Revue Internationale des Sciences Médicales, 15, 95-99.
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dunson, D.B. and Hill, M.C. (2003) Incidence cumulative élevée du léiomyome utérin chez les femmes noires et blanches: Évidence échographique. Journal of Obstetrics and Gynaecology, 188,100-107.
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Aydin, C., Eriş, S., Yalçin, Y. and Şen Selim, H. (2013) A Giant Cystic Leiomyoma Mimicking an Ovarian Malignancy. International Journal of Surgery Case Reports, 4, 1010-1012. &gt;https://doi.org/10.1016/j.ijscr.2013.08.018
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Aboubakari, A.S., Adama-Hongleda, A.B., Darre, T., N’Timon, B., Ajavon, D. and Ak-padza, K. (2015) Dégénérescence kystique de myomes utérins simulant un cancer de l’ovaire: Etude d’un cas au CHU de Kara, Au nord du Togo. European Scientific Journal, 11, 171-176.
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kamiński, P., Kosińska-Kaczyńska, K., Marczewska, J. and Gajewska, M. (2013) Huge Uterine Leiomyoma with Degenerative Changes Mimicking Ovarian Carcinoma—A Case Report. Polish Gynaecology, 84, 147-150. &gt;https://doi.org/10.17772/gp/1556
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Sotomayor, C.G., Parra, C., Miranda, M., Casas, J.S., Cárdenas, G., Sanhueza, Á., et al. (2023) Hyaline and Cystic Degeneration of Uterine Leiomyomas: CT and MR Imaging with Histopathological Sample Analyses. Diagnostics, 13, Article No. 3230. &gt;https://doi.org/10.3390/diagnostics13203230
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Srinidhi, C. and Jajoo, S. (2023) Cystic Degeneration of Uterine Leiomyoma Mimicking Adnexal Mass: A Rare Clinical Image. Pan African Medical Journal, 44, Article No. 20. &gt;https://doi.org/10.11604/pamj.2023.44.20.36747
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mayer, D.P. and Shipilov, V. (1995) Ultrasonography and Magnetic Resonance Imaging of Uterine Fibroids. Obstetrics and Gynecology Clinics of North America, 22, 667-725. &gt;https://doi.org/10.1016/s0889-8545(21)00660-4
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Klatsky, P.C., Tran, N.D., Caughey, A.B. and Fujimoto, V.Y. (2008) Fibroids and Reproductive Outcomes: A Systematic Literature Review from Conception to Delivery. American Journal of Obstetrics and Gynecology, 198, 357-366. &gt;https://doi.org/10.1016/j.ajog.2007.12.039
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Belkharroubi, K., Graichi, R., Remouche, H. and Krelil, B. (2020) Myome utérin géant chez la jeu-ne femme: (À propos de deux cas). Global Scientific Journals, 8, 2764-2768.
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lopes, P., Thibaud, S., Simonnet, R., et al. (1999) Fibromes et grossesse: Quels sont les risques? Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 28, 772-777.
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Levast, F., Legendre, G., Bouet, P.-E. and Sentilhes, L. (2016) Prise en charge des myomes utérins durant la grossesse. Gynécologie Obstétrique&amp;Fertilité, 44, 350-354. &gt;https://doi.org/10.1016/j.gyobfe.2016.04.007
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wallach, E.E. and Vlahos, N.F. (2004) Uterine Myomas: An Overview of Development, Clinical Features, and Management. Obstetrics&amp;Gynecology, 104, 393-406. &gt;https://doi.org/10.1097/01.aog.0000136079.62513.39
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kellal, I., Haddouchi, N.E., Lecuyer, A.-I., Body, G., Perrotin, F. and Marret, H. (2010) Grossesse et fibrome: Quelles complications? Gynécologie Obstétrique&amp;Fertilité, 38, 569-575. &gt;https://doi.org/10.1016/j.gyobfe.2010.08.001
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Munro, M.G., Critchley, H.O.D., Broder, M.S. and Fraser, I.S. (2011) FIGO Classification System (PALM‐COEIN) for Causes of Abnormal Uterine Bleeding in Nongravid Women of Reproductive Age. International Journal of Gynecology&amp;Obstetrics, 113, 3-13. &gt;https://doi.org/10.1016/j.ijgo.2010.11.011
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Soh Victor, K., Roland, A., Ndrin Denis, E., Ramata, K., Privat, A., Zingbe Gondo, S., et al. (2021) Outcome of Myomectomy for Urinary Complications during the Second Trimenon of Pregnancy: 2 Cases Reports at the University Teaching Hospital of Angre/Abidjan. Journal of Gynecology and Obstetrics, 9, 112-115. &gt;https://doi.org/10.11648/j.jgo.20210904.13
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yeh, H.C., Kaplan, M. and Deligdisch, L. (1999) Parasitic and Pedunculated Leiomyomas: Ultrasonographic Features. Journal of Ultrasound in Medicine, 18, 789-794. &gt;https://doi.org/10.7863/jum.1999.18.11.789
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kinkel, K. (2005) Apport de l’IRM dans la prise en charge des fibromes utérins. Imagerie de la Femme, 15, 146-157. &gt;https://doi.org/10.1016/s1776-9817(05)80652-2
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Wladimiroff, J. (2009) Uterine Fibroids. Ultrasound in Obstetrics and Gynecology, 303-306. 
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cassou Roland, A. and Priva, A. (2021) Myomectomy under Cervico-Isthmic Tourniquet: Experience of the Gynecologic-Obstetric Department at the University Teaching Hospital of Cocody (Abidjan). Journal of Gynecology Research Reviews&amp;Reports, 3, 1-3. &gt;https://doi.org/10.47363/jgrrr/2021(3)133
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Winarto, H., Simatupang, O.N.N., Calvin, D., Siregar, T.P. and Andrijono, A. (2023) Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case Report. Journal of Radiology Case Reports, 17, 1-12. &gt;https://doi.org/10.3941/jrcr.v17i4.4583
    </mixed-citation>
   </ref>
   <ref id="scirp.136212-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Torre, L.A., Trabert, B., DeSantis, C.E., Miller, K.D., Samimi, G., Runowicz, C.D., et al. (2018) Ovarian Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 284-296. &gt;https://doi.org/10.3322/caac.21456
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>